AccretivUSA

AccretivUSA

Open  for investment

About this raise

AccretivUSA is raising funds through Reg A+ crowdfunding with Dalmore Group as the Broker-Dealer. It is a wealthcare property fund that invests in medical real estate. AccretivUSA enables investors to invest in healthcare properties through its diversified portfolio and aims to generate consistent returns for investors. The investors are expected to receive rental income from tenants and proceeds from property sales in the form of monthly distributions. Martin Freeman and Justin Clarke founded AccretivUSA in 2024. The current crowdfunding campaign has a maximum target of $75 million. The campaign proceeds will be used for the acquisition of healthcare-related real estate, value-added projects, working capital and reserves, and operating expenses.

Expand

Investment Overview

Committed this round: $0

Deal Terms

Total Commitments ($USD)

Platform
Dalmore Group
Start Date
01/15/2025
Close Date
Not Provided
Min. Goal
$100
Max Goal
$75,000,000
Min. Investment

$100

Security Type

Equity - Preferred

SEC Filing Type

RegA+    Open SEC Filing

Price Per Share

$10.00

Company & Team

Company

Year Founded
2024
Industry
Real Estate & Construction
Tech Sector
Fintech
Location
New York City, New York
Company Website
Visit Website

Team

Funding data not publicly available

Financials

 Revenue
$0
 Cash on Hand
$0

Balance Sheet

Cash and Cash Equivalents

$0

Investment Securities

$0

Accounts and Notes Receivable

$0

Property, Plant and Equipment (PP&E)

$0

Property and Equipment

$0

Total Assets

$0

Accounts Payable & Accrued Liabilities

$0

Long Term Debt

$0

Total Liabilities

$0

Total Stockholders' Equity

$0

Total Liabilities and Equity

$0

Statement of Comprehensive Income Information

Total Revenues

$0

Costs & Expenses Applicable to Rev

$0

Depreciation and Amortization

$0

Net Income

$0

Earnings Per Share - Basic

$0.00

Earnings Per Share - Diluted

$0.00

Auditor: Assurance Dimensions
Create a free account today to gain access to Kingscrowd analytics and financials.

Upgrade to gain access

Pay Monthly
Annually (2 months free)

Edge

$12.50 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific Kingscrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Company Funding & Growth

Funding history

Close Date Platform Valuation Total Raised Security Type Status Reg Type
01/24/2026 Dalmore Group - $0 Equity - Preferred Active RegA+
Create a free account today to gain access to Kingscrowd analytics.
Founders: enhance your startup's credibility on Kingscrowd. Create an account to claim this raise page.
Add to portfolio
AccretivUSA on Dalmore Group 2025
Platform: Dalmore Group
Security Type: Equity - Preferred
Price per Share: $10.00

Follow company

Follow AccretivUSA on Dalmore Group 2025

Buy AccretivUSA's Deal Report

AccretivUSA Deal Report

Get Kingscrowd's comprehensive report on AccretivUSA including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether AccretivUSA is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the AccretivUSA deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge